Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

被引:93
|
作者
Bunnik, Evelien M. [1 ]
Euler, Zelda [1 ]
Welkers, Matthijs R. A. [1 ]
Boeser-Nunnink, Brigitte D. M. [1 ]
Grijsen, Marlous L. [2 ]
Prins, Jan M. [2 ]
Schuitemaker, Hanneke [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect & Immun Amsterdam,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
关键词
NEUTRALIZING ANTIBODY-RESPONSE; TYPE-1; INFECTION; C INFECTION; VIRUS; SENSITIVITY; EVOLUTION; DOMAIN;
D O I
10.1038/nm.2203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By comparing HIV-1 variants from people who became infected at the beginning of the epidemic and from people who have recently contracted the virus, we observed an enhanced resistance of the virus to antibody neutralization over time, accompanied by an increase in the length of the variable loops and in the number of potential N-linked glycosylation sites on the HIV-1 envelope gp120 subunit. The enhanced neutralization resistance of HIV-1 in contemporary seroconverters coincided with the poorer elicitation of neutralizing antibody responses, which may have implications for vaccine design.
引用
收藏
页码:995 / 997
页数:3
相关论文
共 50 条
  • [1] Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
    Evelien M Bunnik
    Zelda Euler
    Matthijs R A Welkers
    Brigitte D M Boeser-Nunnink
    Marlous L Grijsen
    Jan M Prins
    Hanneke Schuitemaker
    Nature Medicine, 2010, 16 : 995 - 997
  • [2] Adaptation of HIV-1 Envelope Glycoprotein gp120 to Humoral Immunity over the Course of the Epidemic
    Bouvin-Pley, Melanie
    Morgand, Marion
    Moreau, Alain
    Meyer, Laurence
    Goujard, Cecile
    Mouquet, Hugo
    Nussenzweig, Michel C.
    Pace, Craig S.
    Ho, David D.
    Bjorkman, Pamela J.
    Baty, Daniel
    Chames, Patrick
    Pancera, Marie
    Kwong, Peter D.
    Poignard, Pascal
    Barin, Francis
    Braibant, Martine
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A224 - A224
  • [3] Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level
    Bunnik, E. M.
    Euler, Z.
    Welkers, M.
    Grijsen, M.
    Prins, J.
    Schuitemaker, H.
    RETROVIROLOGY, 2009, 6
  • [4] Conformation of the HIV-1 gp120 envelope glycoprotein
    Sodroski, J
    Wyatt, R
    Olshevsky, U
    Olshevsky, V
    Moore, J
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 184 - 187
  • [6] Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
    Lekkerkerker, AN
    Ludwig, IS
    van Vliet, SJ
    van Kooyk, Y
    Geijtenbeek, TBH
    VIROLOGY, 2004, 329 (02) : 465 - 476
  • [7] In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120
    Visciano, Maria Luisa
    Tuen, Michael
    Gorny, Miroslaw K.
    Hioe, Catarina E.
    VIROLOGY, 2008, 372 (02) : 409 - 420
  • [8] Role of Cations in the Interaction of Pradimicins with HIV-1 Envelope gp120
    Hoorelbeke, Bart
    Kim, Youngju
    Oki, Toshikazu
    Igarashi, Yasuhiro
    Balzarini, Jan
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (16) : 1907 - 1915
  • [9] HETEROGENEITY IN THE OLIGOSACCHARIDE STRUCTURE OF THE ENVELOPE GLYCOPROTEIN (GP120) OF HIV-1
    RANAJIT, P
    VERONESE, FD
    NAIR, B
    SARNGADHARAN, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 947 - 947
  • [10] Molecular motions of human HIV-1 gp120 envelope glycoproteins
    Shu-Qun Liu
    Shi-Xi Liu
    Yun-Xin Fu
    Journal of Molecular Modeling, 2008, 14 : 857 - 870